Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures:

Multiple Sclerosis Journal – Experimental, Translational and Clinical

Kathryn Trinkaus¹  Laura Piccio²  Becky J Parks³  Enrique Alvarez³  Robert J Mikesell³ 

[1] Biostatistics Shared Resource, Washington University School of Medicine in St Louis, USA;Department of Neurology, University of Colorado Denver, USA;Department of Neurology, Washington University School of Medicine in St Louis, USA

关键词: Rituximab;    outcome measurement;    treatment response;    neurofilament heavy;    MBP;    BAFF;   

DOI  :  10.1177/2055217315623800

学科分类：医学（综合）

来源: Sage Journals

【 授权许可】

CC BY-NC